Clinuvel Pharmaceuticals Statistics
Total Valuation
CUVL has a market cap or net worth of $253.01 million. The enterprise value is $77.50 million.
| Market Cap | 253.01M |
| Enterprise Value | 77.50M |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Sep 8, 2026 |
Share Statistics
CUVL has 50.43 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 50.43M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 10.00% |
| Owned by Institutions (%) | 23.29% |
| Float | 42.06M |
Valuation Ratios
The trailing PE ratio is 10.50 and the forward PE ratio is 10.52.
| PE Ratio | 10.50 |
| Forward PE | 10.52 |
| PS Ratio | 3.89 |
| Forward PS | 3.91 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | 10.24 |
| P/OCF Ratio | 9.80 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.73, with an EV/FCF ratio of 3.14.
| EV / Earnings | 3.30 |
| EV / Sales | 1.19 |
| EV / EBITDA | 2.73 |
| EV / EBIT | 2.76 |
| EV / FCF | 3.14 |
Financial Position
The company has a current ratio of 14.81, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.81 |
| Quick Ratio | 14.34 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.05 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.21% and return on invested capital (ROIC) is 126.71%.
| Return on Equity (ROE) | 13.21% |
| Return on Assets (ROA) | 8.94% |
| Return on Invested Capital (ROIC) | 126.71% |
| Return on Capital Employed (ROCE) | 14.69% |
| Weighted Average Cost of Capital (WACC) | 7.40% |
| Revenue Per Employee | $4.07M |
| Profits Per Employee | $1.47M |
| Employee Count | 16 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 2.01 |
Taxes
In the past 12 months, CUVL has paid $9.51 million in taxes.
| Income Tax | 9.51M |
| Effective Tax Rate | 28.84% |
Stock Price Statistics
The stock price has decreased by -32.11% in the last 52 weeks. The beta is 0.58, so CUVL's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -32.11% |
| 50-Day Moving Average | 5.78 |
| 200-Day Moving Average | 6.92 |
| Relative Strength Index (RSI) | 35.67 |
| Average Volume (20 Days) | 5,806 |
Short Selling Information
The latest short interest is 15,683, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 15,683 |
| Short Previous Month | 26,443 |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 1.72 |
Income Statement
In the last 12 months, CUVL had revenue of $65.05 million and earned $23.46 million in profits. Earnings per share was $0.47.
| Revenue | 65.05M |
| Gross Profit | 54.11M |
| Operating Income | 28.04M |
| Pretax Income | 32.97M |
| Net Income | 23.46M |
| EBITDA | 28.44M |
| EBIT | 28.04M |
| Earnings Per Share (EPS) | $0.47 |
Balance Sheet
The company has $174.37 million in cash and $1.34 million in debt, with a net cash position of $173.03 million or $3.43 per share.
| Cash & Cash Equivalents | 174.37M |
| Total Debt | 1.34M |
| Net Cash | 173.03M |
| Net Cash Per Share | $3.43 |
| Equity (Book Value) | 188.78M |
| Book Value Per Share | 3.74 |
| Working Capital | 183.61M |
Cash Flow
In the last 12 months, operating cash flow was $25.83 million and capital expenditures -$1.12 million, giving a free cash flow of $24.71 million.
| Operating Cash Flow | 25.83M |
| Capital Expenditures | -1.12M |
| Depreciation & Amortization | 403,498 |
| Net Borrowing | -167,002 |
| Free Cash Flow | 24.71M |
| FCF Per Share | $0.49 |
Margins
Gross margin is 83.18%, with operating and profit margins of 43.11% and 36.07%.
| Gross Margin | 83.18% |
| Operating Margin | 43.11% |
| Pretax Margin | 50.69% |
| Profit Margin | 36.07% |
| EBITDA Margin | 43.72% |
| EBIT Margin | 43.11% |
| FCF Margin | 37.55% |
Dividends & Yields
This stock pays an annual dividend of $0.03, which amounts to a dividend yield of 0.58%.
| Dividend Per Share | $0.03 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | 7.89% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.04% |
| FCF Payout Ratio | 5.77% |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.15% |
| Earnings Yield | 9.52% |
| FCF Yield | 9.77% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 12.64% |
| EPS Growth Forecast (3Y) | 13.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CUVL has an Altman Z-Score of 17.18 and a Piotroski F-Score of 5.
| Altman Z-Score | 17.18 |
| Piotroski F-Score | 5 |